Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Direct Thrombectomy vs. Combined Treatment With Intravenous Thrombolysis in the Extended Time Window: A Target Trial Emulation.

European journal of neurology·2026
Same author

Superficial Ventral Premotor Pathways to Primary Motor Cortex Shape the Temporal Coordination of Precision Grasping.

The European journal of neuroscience·2026
Same author

Hippocampal-cortical structural networks in the progression of cognitive impairment: A source-based morphometry analysis in individuals with subjective cognitive decline, mild cognitive impairment and Alzheimer's disease.

Neurobiology of aging·2026
Same author

First-pass effect after acute basilar artery occlusion: a comparison of mechanical thrombectomy techniques.

Journal of neurointerventional surgery·2026
Same author

Eating Disorder Risk Among Italian University Students: A Cross-Sectional Screening Study Using BMI, EAT-26, and EDE-Q 6.0.

Nutrients·2026
Same author

Outcome of patients with dissecting versus atherosclerotic tandem occlusion acute ischemic stroke.

Journal of neurointerventional surgery·2026

Related Experiment Video

Updated: May 16, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Stroke prevention: managing modifiable risk factors.

Silvia Di Legge1, Giacomo Koch, Marina Diomedi

  • 1Stroke Unit, Department of Neuroscience, University of Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.

Stroke Research and Treatment
|December 6, 2012
PubMed
Summary

Preventing ischemic stroke involves managing risk factors and lifestyle changes. Effective secondary prevention strategies include antihypertensive, antiplatelet, and statin therapies, with new anticoagulants offering alternatives for atrial fibrillation patients.

Related Experiment Videos

Last Updated: May 16, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Ischemic stroke is a leading cause of morbidity and mortality.
  • Approximately 50% of strokes are preventable through modifiable risk factor control and lifestyle adjustments.
  • Secondary prevention strategies are vital for reducing recurrent stroke events and vascular complications.

Purpose of the Study:

  • To review the current landscape and recent developments in ischemic stroke prevention.
  • To emphasize medical treatments for secondary stroke prevention.
  • To highlight the role of various pharmacological and interventional strategies.

Main Methods:

  • Review of current medical literature and clinical trial data on stroke prevention.
  • Analysis of established and emerging therapeutic agents.
  • Focus on secondary prevention strategies for ischemic stroke.

Main Results:

  • Antihypertensive treatments, antiplatelets, and statins are crucial for preventing recurrent stroke and vascular events.
  • Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) contribute to vascular health and stroke prevention.
  • Newer anticoagulants (factor Xa inhibitors, direct thrombin inhibitors) offer alternative strategies for atrial fibrillation-related stroke prevention.

Conclusions:

  • Comprehensive management of modifiable risk factors is key to stroke prevention.
  • Pharmacological interventions like antihypertensives, antiplatelets, statins, and anticoagulants are cornerstones of secondary stroke prevention.
  • Advancements in anticoagulation provide more options for patients with atrial fibrillation, enhancing stroke prevention efficacy.